Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALTERITY THERAPEUTICS LTD

0.012
+0.0019.09%
Volume:15.70M
Turnover:184.72K
Market Cap:130.50M
PE:-6.32
High:0.012
Open:0.011
Low:0.011
Close:0.011
52wk High:0.019
52wk Low:0.002
Shares:10.88B
Float Shares:7.47B
Volume Ratio:2.40
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.002
EPS(LYR):-0.002
ROE:-43.23%
ROA:-28.09%
PB:3.08
PE(LYR):-6.32

Loading ...

Company Profile

Company Name:
ALTERITY THERAPEUTICS LTD
Exchange:
ASX
Establishment Date:
1997
Employees:
9
Office Location:
350 Collins Street,Suite 4,Level 14,Melbourne,Victoria,Australia
Zip Code:
3000
Fax:
61 3 9349 4906
Introduction:
Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidates include PBT434 that is in Phase I clinical trial for the treatment of Parkinson's disease and other movement disorders. It is also developing PBT2 for patients with Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. The company was founded in 1997 and is based in Melbourne, Australia.